Group 1 Group 2 Group 3 Group 4 p
Patient survival (%) 93.3 96.4 94.4 92.5 0.696
Death-uncensored graft survival (%) 93.3 82.1 76.1 73.1 0.127
Death-censored graft survival (%) 86.7 78.6 70.4 65.4 0.086
Acute rejection within 12 months after transplantation (%) 33.3 14.3 38 31.3 0.200
Cytomegalovirus infection within 12 months after transplantation (%) 6.7 14.3 16.9 17.9 0.741
eGFR 1 year after transplantation, mean ± SD (mL/min/1.73 m2) 63.1 ± 13.9 60.4 ± 18.5 49.2 ± 15.3 42.6 ± 11.4 <0.001
δeGFR, mean ± SD (mL/min/1.73 m2) 26.5 ± 14.8 18.4 ± 16.5 29.4 ± 18.6 29.7 ± 13.2 0.016
Table 3: Clinical outcomes of recipients in the four groups.